Differential diagnosis of thymic tumors using a combination of 11C- methionine PET and FDG PET

Masayuki Sasaki, Yasuo Kuwabara, Yuichi Ichiya, Yuko Akashi, Tsuyoshi Yoshida, Makoto Nakagawa, Sadayuki Murayama, Kouji Masuda

Research output: Contribution to journalArticle

88 Citations (Scopus)

Abstract

We assessed the usefulness of PET studies in making a differential diagnosis of thymic tumors by using 11C-methionine (MET) and 18F- fluorodeoxyglucose (FDG). Methods: We examined 31 patients with thymic tumors, including 14 patients with thymic cancer, 9 with invasive thymoma, 5 with noninvasive thymoma and 3 with thymic cysts. The histological diagnosis was confirmed by either surgery or biopsy. MET PET and FDG PET were performed in 28 and 29 patients, respectively. Both the MET and FDG uptakes were evaluated by the standardized uptake value (SUV). Results: MET uptake was not substantially different among thymic cancer (4.8 ± 1.4), invasive thymoma (4.3 ± 1.1) and noninvasive thymoma (4.5 ± 1.2), but MET uptake in thymic cysts (0.9 ± 0.1) was lower than that in the other three tumors (P < 0.01). The FDG uptake in thymic cancer (7.2 ± 2.9) was higher than that in invasive thymoma (3.8 ± 1.3), noninvasive thymoma (3.0 ± 1.0) and thymic cysts (0.9) (P < 0.01). MET uptake in thymic tumors correlated with the FDG uptake (r = 0.65), whereas MET uptake in thymic cancer was lower than FDG uptake (FDG/MET ratio = 1.52 ± 0.52) but was higher than FDG uptake in both invasive and noninvasive thymoma (FDG/MET ratio = 0.86 ± 0.33). To differentiate thymic cancer from thymoma, a receiver operating characteristic (ROC) analysis was performed. The area under the curve of FDG PET was 0.90, whereas the FDG/MET ratio was 0.87. Conclusion: The MET PET, FDG PET and the FDG/MET ratios were unable to differentiate benign thymic tumors from malignant ones, although FDG PET was considered to be useful in the differential diagnosis between thymic cancer and thymoma. Although the difference in the uptake ratio between FDG and MET suggests a different origin of the tumors, the FDG/MET ratio is not considered to be useful as a complementary method for the differential diagnosis of thymic tumors.

Original languageEnglish
Pages (from-to)1595-1601
Number of pages7
JournalJournal of Nuclear Medicine
Volume40
Issue number10
Publication statusPublished - Oct 1 1999

Fingerprint

Thymus Neoplasms
Methionine
Differential Diagnosis
Thymoma
Mediastinal Cyst
Fluorodeoxyglucose F18

All Science Journal Classification (ASJC) codes

  • Radiology Nuclear Medicine and imaging

Cite this

Sasaki, M., Kuwabara, Y., Ichiya, Y., Akashi, Y., Yoshida, T., Nakagawa, M., ... Masuda, K. (1999). Differential diagnosis of thymic tumors using a combination of 11C- methionine PET and FDG PET. Journal of Nuclear Medicine, 40(10), 1595-1601.

Differential diagnosis of thymic tumors using a combination of 11C- methionine PET and FDG PET. / Sasaki, Masayuki; Kuwabara, Yasuo; Ichiya, Yuichi; Akashi, Yuko; Yoshida, Tsuyoshi; Nakagawa, Makoto; Murayama, Sadayuki; Masuda, Kouji.

In: Journal of Nuclear Medicine, Vol. 40, No. 10, 01.10.1999, p. 1595-1601.

Research output: Contribution to journalArticle

Sasaki, M, Kuwabara, Y, Ichiya, Y, Akashi, Y, Yoshida, T, Nakagawa, M, Murayama, S & Masuda, K 1999, 'Differential diagnosis of thymic tumors using a combination of 11C- methionine PET and FDG PET', Journal of Nuclear Medicine, vol. 40, no. 10, pp. 1595-1601.
Sasaki M, Kuwabara Y, Ichiya Y, Akashi Y, Yoshida T, Nakagawa M et al. Differential diagnosis of thymic tumors using a combination of 11C- methionine PET and FDG PET. Journal of Nuclear Medicine. 1999 Oct 1;40(10):1595-1601.
Sasaki, Masayuki ; Kuwabara, Yasuo ; Ichiya, Yuichi ; Akashi, Yuko ; Yoshida, Tsuyoshi ; Nakagawa, Makoto ; Murayama, Sadayuki ; Masuda, Kouji. / Differential diagnosis of thymic tumors using a combination of 11C- methionine PET and FDG PET. In: Journal of Nuclear Medicine. 1999 ; Vol. 40, No. 10. pp. 1595-1601.
@article{eb40700dca8e472f9f34f0685f247893,
title = "Differential diagnosis of thymic tumors using a combination of 11C- methionine PET and FDG PET",
abstract = "We assessed the usefulness of PET studies in making a differential diagnosis of thymic tumors by using 11C-methionine (MET) and 18F- fluorodeoxyglucose (FDG). Methods: We examined 31 patients with thymic tumors, including 14 patients with thymic cancer, 9 with invasive thymoma, 5 with noninvasive thymoma and 3 with thymic cysts. The histological diagnosis was confirmed by either surgery or biopsy. MET PET and FDG PET were performed in 28 and 29 patients, respectively. Both the MET and FDG uptakes were evaluated by the standardized uptake value (SUV). Results: MET uptake was not substantially different among thymic cancer (4.8 ± 1.4), invasive thymoma (4.3 ± 1.1) and noninvasive thymoma (4.5 ± 1.2), but MET uptake in thymic cysts (0.9 ± 0.1) was lower than that in the other three tumors (P < 0.01). The FDG uptake in thymic cancer (7.2 ± 2.9) was higher than that in invasive thymoma (3.8 ± 1.3), noninvasive thymoma (3.0 ± 1.0) and thymic cysts (0.9) (P < 0.01). MET uptake in thymic tumors correlated with the FDG uptake (r = 0.65), whereas MET uptake in thymic cancer was lower than FDG uptake (FDG/MET ratio = 1.52 ± 0.52) but was higher than FDG uptake in both invasive and noninvasive thymoma (FDG/MET ratio = 0.86 ± 0.33). To differentiate thymic cancer from thymoma, a receiver operating characteristic (ROC) analysis was performed. The area under the curve of FDG PET was 0.90, whereas the FDG/MET ratio was 0.87. Conclusion: The MET PET, FDG PET and the FDG/MET ratios were unable to differentiate benign thymic tumors from malignant ones, although FDG PET was considered to be useful in the differential diagnosis between thymic cancer and thymoma. Although the difference in the uptake ratio between FDG and MET suggests a different origin of the tumors, the FDG/MET ratio is not considered to be useful as a complementary method for the differential diagnosis of thymic tumors.",
author = "Masayuki Sasaki and Yasuo Kuwabara and Yuichi Ichiya and Yuko Akashi and Tsuyoshi Yoshida and Makoto Nakagawa and Sadayuki Murayama and Kouji Masuda",
year = "1999",
month = "10",
day = "1",
language = "English",
volume = "40",
pages = "1595--1601",
journal = "Journal of Nuclear Medicine",
issn = "0161-5505",
publisher = "Society of Nuclear Medicine Inc.",
number = "10",

}

TY - JOUR

T1 - Differential diagnosis of thymic tumors using a combination of 11C- methionine PET and FDG PET

AU - Sasaki, Masayuki

AU - Kuwabara, Yasuo

AU - Ichiya, Yuichi

AU - Akashi, Yuko

AU - Yoshida, Tsuyoshi

AU - Nakagawa, Makoto

AU - Murayama, Sadayuki

AU - Masuda, Kouji

PY - 1999/10/1

Y1 - 1999/10/1

N2 - We assessed the usefulness of PET studies in making a differential diagnosis of thymic tumors by using 11C-methionine (MET) and 18F- fluorodeoxyglucose (FDG). Methods: We examined 31 patients with thymic tumors, including 14 patients with thymic cancer, 9 with invasive thymoma, 5 with noninvasive thymoma and 3 with thymic cysts. The histological diagnosis was confirmed by either surgery or biopsy. MET PET and FDG PET were performed in 28 and 29 patients, respectively. Both the MET and FDG uptakes were evaluated by the standardized uptake value (SUV). Results: MET uptake was not substantially different among thymic cancer (4.8 ± 1.4), invasive thymoma (4.3 ± 1.1) and noninvasive thymoma (4.5 ± 1.2), but MET uptake in thymic cysts (0.9 ± 0.1) was lower than that in the other three tumors (P < 0.01). The FDG uptake in thymic cancer (7.2 ± 2.9) was higher than that in invasive thymoma (3.8 ± 1.3), noninvasive thymoma (3.0 ± 1.0) and thymic cysts (0.9) (P < 0.01). MET uptake in thymic tumors correlated with the FDG uptake (r = 0.65), whereas MET uptake in thymic cancer was lower than FDG uptake (FDG/MET ratio = 1.52 ± 0.52) but was higher than FDG uptake in both invasive and noninvasive thymoma (FDG/MET ratio = 0.86 ± 0.33). To differentiate thymic cancer from thymoma, a receiver operating characteristic (ROC) analysis was performed. The area under the curve of FDG PET was 0.90, whereas the FDG/MET ratio was 0.87. Conclusion: The MET PET, FDG PET and the FDG/MET ratios were unable to differentiate benign thymic tumors from malignant ones, although FDG PET was considered to be useful in the differential diagnosis between thymic cancer and thymoma. Although the difference in the uptake ratio between FDG and MET suggests a different origin of the tumors, the FDG/MET ratio is not considered to be useful as a complementary method for the differential diagnosis of thymic tumors.

AB - We assessed the usefulness of PET studies in making a differential diagnosis of thymic tumors by using 11C-methionine (MET) and 18F- fluorodeoxyglucose (FDG). Methods: We examined 31 patients with thymic tumors, including 14 patients with thymic cancer, 9 with invasive thymoma, 5 with noninvasive thymoma and 3 with thymic cysts. The histological diagnosis was confirmed by either surgery or biopsy. MET PET and FDG PET were performed in 28 and 29 patients, respectively. Both the MET and FDG uptakes were evaluated by the standardized uptake value (SUV). Results: MET uptake was not substantially different among thymic cancer (4.8 ± 1.4), invasive thymoma (4.3 ± 1.1) and noninvasive thymoma (4.5 ± 1.2), but MET uptake in thymic cysts (0.9 ± 0.1) was lower than that in the other three tumors (P < 0.01). The FDG uptake in thymic cancer (7.2 ± 2.9) was higher than that in invasive thymoma (3.8 ± 1.3), noninvasive thymoma (3.0 ± 1.0) and thymic cysts (0.9) (P < 0.01). MET uptake in thymic tumors correlated with the FDG uptake (r = 0.65), whereas MET uptake in thymic cancer was lower than FDG uptake (FDG/MET ratio = 1.52 ± 0.52) but was higher than FDG uptake in both invasive and noninvasive thymoma (FDG/MET ratio = 0.86 ± 0.33). To differentiate thymic cancer from thymoma, a receiver operating characteristic (ROC) analysis was performed. The area under the curve of FDG PET was 0.90, whereas the FDG/MET ratio was 0.87. Conclusion: The MET PET, FDG PET and the FDG/MET ratios were unable to differentiate benign thymic tumors from malignant ones, although FDG PET was considered to be useful in the differential diagnosis between thymic cancer and thymoma. Although the difference in the uptake ratio between FDG and MET suggests a different origin of the tumors, the FDG/MET ratio is not considered to be useful as a complementary method for the differential diagnosis of thymic tumors.

UR - http://www.scopus.com/inward/record.url?scp=0032886667&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0032886667&partnerID=8YFLogxK

M3 - Article

VL - 40

SP - 1595

EP - 1601

JO - Journal of Nuclear Medicine

JF - Journal of Nuclear Medicine

SN - 0161-5505

IS - 10

ER -